Clinical Significance of Combined Detection of CCL22 and IL‐1 as Potential New Bronchial Inflammatory Mediators in Children's Asthma
Our results show that CCL22 and IL-1 are both representative markers during asthma symptom exacerbations and an immune mediator that can predict response to azithromycin therapy.
Authors
- Xinyang Song (ORCID: https://orcid.org/0000-0002-3422-6927)
- Yanping Peng
- Lei Cui (ORCID: https://orcid.org/0000-0002-2598-0637)
- Min Shi (ORCID: https://orcid.org/0009-0005-7892-0055)
Institutions
- Jishou University (CN)
Publication Details
- Journal
- Immunity Inflammation and Disease
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1002/iid3.70043
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00